Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$3.71 USD
+0.44 (13.46%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $3.70 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Aveanna Healthcare (AVAH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$2.64 | $3.00 | $1.70 | -19.27% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Aveanna Healthcare comes to $2.64. The forecasts range from a low of $1.70 to a high of $3.00. The average price target represents a decline of 19.27% from the last closing price of $3.27.
Analyst Price Targets (5 )
Broker Rating
Aveanna Healthcare currently has an average brokerage recommendation (ABR) of 3.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 3.25 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, one is Strong Buy, representing 12.5% of all recommendations. A month ago, Strong Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 1 | 1 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 3.25 | 3.25 | 3.25 | 3.33 | 3.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/7/2024 | Not Identified | Not Identified | Hold | Hold |
4/15/2024 | Truist Securities | David S Macdonald | Hold | Hold |
4/1/2024 | Stephens | Scott Fidel | Hold | Hold |
11/30/2023 | UBS | Aj Rice | Not Available | Strong Sell |
11/10/2023 | Raymond James | John W Ransom | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.25 |
ABR (Last week) | 3.25 |
# of Recs in ABR | 8 |
Average Target Price | $2.64 |
LT Growth Rate | NA |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 69 of 253 |
Current Quarter EPS Est: | -0.02 |